Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 00591-0369-01.

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Recall #: D-1399-2012
Affected scope: 8254 bottles
Initiated: April 17, 2012

Compiled from official public sources by the publisher. · Updated September 2026

Watson Laboratories Inc recalled Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratorie… - a low-severity action.

Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratorie… was recalled by Watson Laboratories Inc in July 11, 2012. Reason: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packag…. Check the official notice for the remedy. Verify recall #D-1399-2012 with the FDA Drug before acting.

The recall

Watson Laboratories Inc issued this low-severity FDA Drug recall-Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packag….

Low
severity level: Class III
classification: July 11, 2012
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1399-2012 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 1 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 00591-0369-01.

Reason for recall

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Terminated
Recall number	D-1399-2012
Date reported	July 11, 2012
Date initiated	April 17, 2012
Recalling firm	Watson Laboratories Inc
Firm location	Corona, CA
Affected scope	8254 bottles
Distribution	Nationwide.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-1399-2012) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 00591-0369-01.. Recalled by Watson Laboratories Inc. Units affected: 8254 bottles.

Why was this product recalled? ▼

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on July 11, 2012. Severity: Low. Recall number: D-1399-2012.

Where was the recalled product distributed? ▼

Distribution: Nationwide..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

Imodium Multi-Symptom Relief Caplets, Lop… 2012-07-11 Balnetar Therapeutic Tar Bath, Coal Tar U… 2012-07-11 Dannon Fruit on the Bottom, Raspberry fla… 2012-07-11 Dannon Fruit on the Bottom, Mixed Berry f… 2012-07-11

Similar Children & Baby Products · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Troxel Recalls Flexible Flyer Swing Sets … 2012-07-11 Rosati Cry Baby Sour Watermelon water ice… 2012-07-11 Old Navy Recalls Toddler Girl Aqua Socks … 2012-07-12 Trampolines Recalled by Panline USA Due t… 2012-07-18

Compare this recall with CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per … → · All Children & Baby Products recalls

This recall: FDA Drug, reported July 11, 2012. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026